Improving kidney graft function from brain-dead organ donors
Official title: Impact of Perioperative Organ Resuscitation of Brain-dead Deceased Organ Donor on Kidney Graft Function in the Recipient
Run by University Hospital, Strasbourg, France · NCT06907758 · Data updated 2026-11-12
This study looks at how the care given to brain-dead organ donors can improve the function of kidneys transplanted to patients waiting for a transplant.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | April 10, 2024 |
| Main results expected | December 10, 2025 |
| Study ends | December 10, 2025 |
| Registry record updated | April 2, 2025 |
| Trial ID | NCT06907758 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult brain-dead organ donors and adult recipients of kidney transplants from these donors at Strasbourg University Hospital.
✕Probably not a fit
Patients who are not undergoing kidney transplantation or those who do not meet the donor or recipient criteria will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates how perioperative care of brain-dead organ donors can affect the quality and function of kidney grafts transplanted to recipients. By focusing on potentially modifiable factors in donor management, the study aims to enhance graft performance and reduce waiting times for kidney transplants. The research will analyze data from adult brain-dead patients who have undergone multi-organ transplantation and whose kidneys have been transplanted at Strasbourg University Hospital.
Why it matters
Potential benefit: If successful, this study could lead to improved kidney transplant outcomes and shorter waiting times for patients in need of a kidney.
How similar studies have gone: While the approach of optimizing donor management is established, the specific focus on perioperative organ resuscitation in brain-dead donors for kidney grafts is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: The inclusion criteria for organ donor patients are as follows: * Adult patient * Brain dead * Hospitalized in surgical intensive care at Strasbourg University Hospital (NHC cardiovascular intensive care unit, NHC multi-purpose intensive care unit, Hautepierre surgical intensive care unit) from January 1, 2018 to December 31, 2023 * Having undergone multi-organ transplantation * At least one of the donor kidneys has been transplanted to a patient at Strasbourg University Hospital * Absence of written objection in the medical file of the subject (and/or their legal representative, if applicable) to the reuse of their data for scientific research purposes. The inclusion criteria for kidney transplant recipients are as follows: * Adult patient * Recipient of a kidney transplant from an organ donor who meets the inclusion criteria for donor patients mentioned above * Patient who has undergone surgery and is hospitalized post-operatively at Strasbourg University Hospital * Patient monitored by the Strasbourg University Hospital transplant team * Absence of written objection in the subject's medical file (and/or their legal representative, if applicable) to the reuse of their data for scientific research purposes. Exclusion Criteria: * Subject (and/or their legal representative, if applicable) who has expressed their opposition to the reuse of their data for scientific research purposes * Brain-dead patient who has not undergone organ retrieval * Brain-dead patient whose kidney has not been allocated to a recipient in Strasbourg * Patient transferred to the Strasbourg University Hospital's intensive care unit from another hospital in a state of already diagnosed brain death solely for organ retrieval * Kidney transplant patient with a graft from a living donor * Kidney transplant patient with a graft from a deceased donor who is not brain-dead * Kidney transplant patient with a graft from a deceased donor who is brain-dead and hospitalized in a hospital other than Strasbourg
Where it's running
-
Service d'Anesthésie, Réanimation et Médecine Périopératoire - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Charlotte POUSSARDIN, MD
- Email: charlotte.poussardin@chru-strasbourg.fr
- Phone: 33.3.69.55.16.21
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Patient-specific biomechanical modeling of incisional hernias with AI and finite element analysis
Researchers will test a personalized computer model of the abdominal wall for adults with incisional hernias using anonymized CT data and AI to see how the hernia shapes relate to tissue mechanics.
-
Menin inhibitors in pediatric relapsed or refractory acute leukemia
This study looks at kids with relapsed or treatment-resistant acute leukemia who have specific genetic changes and are treated with menin inhibitors to see how they fare.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Predictors of Success and Failure of v-NOTES Hysterectomy for Large Uteri
This study looks at which factors predict whether a v-NOTES hysterectomy for large uteri will be completed without needing to switch to another surgical approach.
-
Prehospital end-of-life care: how professionals use a comfort care booklet in Strasbourg
This study tests how emergency crew members in Strasbourg use a comfort care booklet when caring for patients at end of life, and what they think about it.
-
Toxicity of intensive first-line treatment for adult Burkitt lymphoma
This study looks back at adult Burkitt lymphoma patients treated with very aggressive first-line chemotherapy to see how toxic the treatment is and what their long-term outcomes were.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.